Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04758702 · ClinicalTrials.gov registry record · Phase 1

The Clinical Impact of L-PRF, H-PRF or the Use of Surgical Stent on Palatal Donor Site Healing.

A Phase 1 study of Lack of Keratinized Gingiva, sponsored by Abdo Y Ismail.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT04758702 is a Phase 1 study of Lack of Keratinized Gingiva that has completed, run by Abdo Y Ismail. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04758702, a Phase 1 study of Lack of Keratinized Gingiva, has completed, sponsored by Abdo Y Ismail.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

A Randomized, Three Parallel Arms Clinical Trial to evaluate s the clinical impact of L-PRF vs H-PRF vs Palatal stent on the healing of the donor palatal site.

Interventions

  • BIOLOGICAL L-PRF (Leucocyte- platelet rich fibrin)
  • BIOLOGICAL H-PRF (Horizontal -platelet rich fibrin)
  • DEVICE Surgical stent

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-02-24
Est. Completion 2023-05-25
Phase Phase 1

Sponsor

Abdo Y Ismail

1 total trials

What the Registry Record Tells You About NCT04758702

The ClinicalTrials.gov registry entry for NCT04758702 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abdo Y Ismail, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lack of Keratinized Gingiva appearing as the primary indexed condition, and to 3 interventions - of which L-PRF (Leucocyte- platelet rich fibrin) is the first listed.

NCT04758702 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT04758702 about?

NCT04758702 is a clinical study titled "The Clinical Impact of L-PRF, H-PRF or the Use of Surgical Stent on Palatal Donor Site Healing.". A Randomized, Three Parallel Arms Clinical Trial to evaluate s the clinical impact of L-PRF vs H-PRF vs Palatal stent on the healing of the donor palatal site.

What is the current status of trial NCT04758702?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2021-02-24. Estimated completion is 2023-05-25.

What conditions does trial NCT04758702 study?

This clinical trial studies the following conditions: Lack of Keratinized Gingiva.

What interventions are being tested in trial NCT04758702?

The interventions under investigation include: L-PRF (Leucocyte- platelet rich fibrin) (BIOLOGICAL), H-PRF (Horizontal -platelet rich fibrin) (BIOLOGICAL), Surgical stent (DEVICE).

Who is sponsoring clinical trial NCT04758702?

This trial is sponsored by Abdo Y Ismail, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04758702 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lack of Keratinized Gingiva

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.